The Smart Hearing Alliance

Delivering state-of-the-art bimodal solutions to you and your patients.

Dedicated to the journey

Since 2011, Cochlear and ReSound have collaborated in the Smart Hearing Alliance to provide hearing solutions for patients with varying degrees of hearing loss.

As part of our dedication to your patients, the Smart Hearing Alliance has introduced a new range of dedicated bimodal solutions, evolving from broad hearing aid compatibility toward a more focused partnership between Cochlear and ReSound. This enables more targeted technology development, helping optimize signal processing, connectivity, and overall performance across specific hearing aid and cochlear implant pairings. For you, this means data driven patient outcomes to help effectively meet the changing needs of your patients over time.

Learn more

In a survey of 360 recipients, 89% of recipients with a SHA solution, continued using their contralateral hearing aid after cochlear implantation.1

SHA bimodal hearing percentages

For patients seeking the most reliable, smallest, lightest bimodal solution with a wide fitting range, the Nucleus® 8 Sound Processor and ReSound Sensia™ microRIE Bimodal delivers.3-7

  • Cochlear™ Nucleus implants are the most reliable over 10, 20 and 30 years.8-10
  • Access to ReSound’s latest technology.
  • Wide fitting range to best meet your patients hearing needs.3,6
  • Patient choice of hearing aid model and colors to best meet their lifestyle.
  • Direct bimodal streaming from compatible Apple® and Android™ devices.*
  • Ready for the next generation Bluetooth® LE Audio/Auracast® connectivity.~

More information

nucleus-profile-plus-series-cochlear-implant_600x400.jpg

Nucleus® Implant Information Center

Find information about implants, electrodes and beyond.

Read more
Supporting patient upgrades Hero.jpg

Supporting patient upgrades

Resources to help you efficiently support upgrades.

Read more
CAM-MK-WEB-4108-Header-image.jpg

Cochlear® Nucleus® systems

A cochlear implant is an established, effective and long term solution for people with moderate to profound hearing loss.

Read more

Disclaimer

This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

ReSound is a trademark of GN Hearing A/S.

Android, Google Play and the Google Play logo are trademarks of Google LLC.

Apple, the Apple logo, FaceTime, Made for iPad logo, Made for iPhone logo, Made for iPod logo, iPhone, iPad Pro, iPad Air, iPad mini, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc., registered in the U.S. and other countries.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Cochlear Limited is under license.

*For compatibility information and devices visit www.cochlear.com/compatibility and www.resound.com/compatibility

~When the technology becomes available for the Cochlear Nucleus 8 Sound Processor, a firmware update to your sound processor will allow you to connect to Bluetooth LE Audio compatible devices.

References

  1. Cochlear Limited. D2277636. Experiences and opinions of bimodal hearing: a survey of UK adult cochlear implant recipients. November 2024.
  2. Lupo J, Biever A, Kelsall D. Comprehensive hearing aid assessment in adults with bilateral severe-profound sensorineural hearing loss who present for Cochlear implant evaluation. American Journal of Otolaryngology. 2020;41(2):102300.3. GN ReSound. Data on File. 2023.
  3. GN ReSound. Data on File. 2023.
  4. Cochlear. FUN4737 Bimodal Hearing Evidence Summary. Volume 1 JUN 2022.
  5. Cochlear Limited 2022. D1998842. CP1110 Technical Specifications.
  6. Phonak Naída™ Marvel 027-0571-02/V2.00/2019-11/cu. Sonova and affiliates; 2019. Available from https://www.phonakpro.com/content/dam/phonakpro/gc_hq/en/products_solutions/hearing_aid/naida_marvel/documents/product_information_naida_m-sp_027-0571.pdf
  7. Naída CI M90 Sound Processor Data Sheet. 027-N237-02 Rev C. Advanced Bionics AG and affiliates; 2022. Available https://www.advancedbionics.com/content/dam/advancedbionics/Documents/libraries/marvel-ci-product-support/com-en/Naida-CI-M90-Sound-Processor-Data-Sheet.pdf
  8. Cochlear Limited. D1712883 V1 2026-03. Cochlear Nucleus Reliability Report (Simplified) Volume 24, December 2025.
  9. Advanced Bionics Reliability Report July 2025. 028-Q048-02 Rev G. Advanced Bionics AG and affiliates.; 2025.
  10. MED-EL Cochlear Implant Systems Reliability Report October 2025. M00815 r7.0. MED-EL Medical Electronics.; 2025.